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Abstract BACKGROUND CONTEXT: Evidence is lacking on the prognosis and prognostic factors of back-
related leg pain and sciatica in patients seeing their primary care physicians. This evidence could
guide timely appropriate treatment and referral decisions.
PURPOSE: The present study aims to describe the prognosis and prognostic factors in primary care
patients with low back-related leg pain and sciatica.
STUDY DESIGN: This is a prospective cohort study.
PATIENT SAMPLE: The present study included adults visiting their family doctor with back-
related leg pain in the United Kingdom.
OUTCOME MEASURES: Information about pain, function, psychological, and clinical vari-
ables, was collected. Good outcome was defined as 30% or more reduction in disability (Roland-
Morris Disability Questionnaire).
METHODS: Participants completed the questionnaires, underwent clinical assessments, received
a magnetic resonance imaging scan, and were followed-up 12 months later. Mixed-effects logistic
regression evaluated the prognostic value of six a priori defined variable sets (leg pain duration, pain
intensity, neuropathic pain, psychological factors, clinical examination, and imaging variables). A
combined model, including variables from all models, examined independent effects. The National
Institute for Health Research funded the study. There are no conflicts of interest.
RESULTS: A total of 609 patients were included. At 12 months, 55% of patients improved in both
the total sample and the sciatica group. For the whole cohort, longer leg pain duration (odds ratio
[OR] 0.41; confidence interval [CI] 0.19–0.90), higher identity score (OR 0.70; CI 0.53–0.93), and
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patient’s belief that the problem will last a long time (OR 0.27; CI 0.13–0.57) were the strongest
independent prognostic factors negatively associated with improvement. These last two factors were
similarly negatively associated with improvement in the sciatica subgroup.
CONCLUSIONS: The present study provides new evidence on the prognosis and prognostic factors
of back-related leg pain and sciatica in primary care. Just over half of patients improved at 12 months.
Patient’s belief of recovery timescale and number of other symptoms attributed to the pain are in-
dependent prognostic factors. These factors can be used to inform and direct decisions about timing
and intensity of available therapeutic options. © 2017 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Introduction
Low back pain (LBP) is the leading cause of years lived
with disability worldwide [1] and one of the most common
reasons for seeking healthcare for musculoskeletal pain [2].
Approximately 60% of patients visiting primary care with LBP
report back-related leg pain [3]. Some patients will have symp-
toms of nerve root entrapment (commonly described as
sciatica), and some will have referred leg pain, which does
not involve a nerve root. Both presentations are associated
with worse overall outcomes compared to LBP alone [3,4].
The course of back-related leg pain and sciatica in primary
care is often conflated with that of nonspecific LBP, as most
LBP cohorts include patients with and without leg symp-
toms [5] and initial management advice is similar for both
nonspecific and sciatica presentations [6].
Given the high probability of long-standing pain and dis-
ability in nonspecific LBP, and limited potential for diagnostic
information to guide clinical decision-making, much re-
search has focused on describing prognosis and identifying
prognostic factors [7,8] which supports planning of health-
care resources and can underpin appropriate management
decisions. Knowledge of prognostic factors in LBP seems to
have led to better treatment decision-making and improved
health and cost outcomes [9]. Such evidence is scarce for pa-
tients resenting to primary care with back-related leg pain and
sciatica [10,11]. The limited, and sometimes conflicting, ev-
idence regarding prognostic factors in patients with sciatica
hampers effective targeting of available treatments [10–14];
hence, the current model of care is a “stepped” escalation of
available interventions [15].
Systematic reviews of predominantly secondary care cohorts
indicate that factors such as age, gender, smoking, occupa-
tional workload, and neurological deficits are unlikely to be
associated with outcome in sciatica [10–12]. High leg pain
intensity predicted surgical intervention (which is a proxy for
poor outcome with conservative management) [11], al-
though this factor was not significantly associated with
outcome in recent research [16]. For sciatica in particular,
authors have suggested that clinical decision-making is ham-
pered by the lack of evidence on prognostic factors and the
almost nonexistent evidence from primary care, the setting
where most patients are assessed and managed [11]. Studies
investigating prognosis and prognostic factors in back-
related leg pain including sciatica, with a focus in primary
care, are therefore needed.
The aims of this study were (1) to describe the overall prog-
nosis, (2) better understand the associations between potentially
important prognostic factors and disability, and (3) identify
the strongest factors independently associated with disability.
Methods
Study design and participant recruitment procedures
This is a prospective cohort study including patients aged
18 years and older, visiting their family doctor (general prac-
titioner [GP]) with symptoms of low back-related leg pain,
including sciatica, of any severity and duration. The project
was approved in accordance with the agreed procedure with
the South Birmingham Research Ethics Committee (REC Ref.
10/H1207/82). The study protocol, baseline assessments, and
patients’ characteristics are reported in detail elsewhere [17,18].
Here, we give brief details of the recruitment process. Po-
tentially eligible patients were identified consecutively at the
GP consultation and through weekly downloads of electron-
ic records with a diagnostic code of low back-related leg pain.
Patients were sent a letter with an invitation to telephone the
research center to make an appointment at the initial re-
search clinic, information about the study, and baseline
questionnaires capturing sociodemographic, pain, psycho-
logical, and health variables. At the research clinic, patients
underwent a standardized clinical examination by a physio-
therapist with experience in assessment and management of
LBP and sciatica, and eligibility was further assessed. Pa-
tients were diagnosed having sciatica or referred (nonspecific)
leg pain based on the examiner’s clinical opinion. In the context
of the study, sciatica diagnosis is indicative of radicular pain
with or without radiculopathy (nerve root involvement/
compression). A reliability study nested in this cohort showed
acceptable agreement on diagnosis [19]. Exclusion criteria
were “red flag” symptoms, language problems, previous spinal
surgery, being pregnant, serious mental and/or physical dis-
orders, and currently receiving treatment (other than GP care)
for the same problem. Consenting, eligible patients without
contraindications to magnetic resonance imaging (MRI)
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received a scan within 2 weeks of their baseline examina-
tion (details of the scan parameters and reporting are fully
described elsewhere [17]). Patients completed self-reported
questionnaires at baseline, 4 months, and 12 months. Pa-
tients received evidence-based care according to current
national and international guidelines on the management of
LBP and sciatica, which was recorded on case report forms,
and their participation in the study did not confer any spe-
cific advantages or benefits as a result. The results of the MRI
scan were not included in initial diagnosis and decisions about
patient care; this reflects normal practice in primary care set-
tings. However, the MRI findings for each patient were
correlated with the clinical presentation for the MRI vari-
able of “presence/absence of nerve root compression.”
Primary outcome measure
The Roland-Morris Disability Questionnaire (RMDQ) leg
pain version (23 items scored from 0 to 23, with higher scores
indicating higher disability) was the primary outcome measure
[20]. Improvement was defined as 30% or more decrease in
an individual’s RMDQ score between baseline and follow-
up [21].
Potential prognostic factors
Prognostic factors to be examined were a priori selected
based on evidence of their association with long-term outcome,
building on exploratory evidence from existing studies in LBP
and sciatica, and expertise within the study team. The self-
reported and clinical assessment variables investigated in the
study are summarized in Table 1.
Treatment pathways
Participants were managed according to one of three care
pathways: (1) up to two physiotherapy sessions for those pa-
tients with improving or mild symptoms, (2) a course of
physiotherapy treatment (three and more) for those patients
with more troublesome pain, and (3) referral to secondary care;
most patients in this pathway initially received a course of
physiotherapy treatment. Secondary care options included
Table 1
List of the preselected sets of variables used in the analysis
Variable set Domain Measure
1 Duration of pain Current episode of leg pain: Less than 6 wk, between 6 and 12 wk, more than 3 mo
2 Pain intensity Taking the highest of either back or leg pain using the mean of three 0 to 10 numerical rating scales for
“least,” “usual,” and “current” pain over the previous 2 wk [22]
3 Neuropathic pain features Using the Leeds Assessment Neuropathic Symptoms and Signs (S-LANSS); with a score of 12 or more
indicating possible neuropathic pain [23]
4 Psychological perceptions Pain self-efficacy: Measured with the Pain Self-Efficacy Questionnaire (PSEQ); with scores from 0 to
60; higher scores reflect stronger self-efficacy beliefs [24]
Identity; Symptom attribution to the condition [25] from a list of seven potential symptoms: back pain,
leg pain, unable to sit comfortably, fatigue, stiff joints, sleep difficulties, loss of strength. The score is
the sum of symptoms experienced. The list of the seven potential symptoms was chosen by the
research team.
Timeline; illness/condition duration: “My back and/or leg problem will last for a long time”*
Personal control: How much influence a patient has over illness/condition; “There is a lot which I can do
to control my back and/or leg symptoms”*
Depression: Measured using the Hospital Anxiety and Depression scale (HADs); with scores from 0 to
21, higher scores indicate higher levels of depressive symptoms [26]
5 Clinical examination Pins and needles or numbness in leg(s) as reported by the patient.
Leg pain increased by coughing/laughing/straining.
Worse pain, either in low back or leg.
Neurological examination variables:
–Myotomal strength†: Defined as normal (5 on Oxford scale)/abnormal (0, 1, 2, 3, or 4 on Oxford scale)
–Reflex (tendon): Defined as normal, slightly reduced, significantly reduced/absent
–Sensation‡ (in leg(s)) Defined as normal/abnormal
–Neural tension test findings: Defined as abnormal if any neural tension test is abnormal (ie, straight leg
raise, femoral stretch, slump)
6 Imaging (MRI) examination MRI findings: Defined as normal when no evidence of nerve root compression correlating with clinical
symptoms, or indicative of nerve root compression if there was evidence of clear or possible nerve
root compression for any reason. All MRIs were scored by the same experienced consultant
radiologist who had no knowledge of the specific patient presentation other than “LBP with leg pain.”
LBP, low back pain; MRI, magnetic resonance imaging.
* Timeline and Personal control are measured on a Likert scale: Strongly disagree—Disagree—Neither agree or disagree—Agree—Strongly agree. For
the purposes of the analysis, it was dichotomized (agree [agree, strongly agree] vs. disagree [strongly disagree, disagree, neither agree, or disagree]).
† Muscle strength tested according to the Oxford scale, where 0, no movement; 1, flicker of movement; 2, through full range actively with gravity coun-
terbalanced; 3, through full range actively against gravity; 4, through full range actively against some resistance; 5, through full range actively against strong
resistance.
‡ Sensation was tested with a pin (neurotip).
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referral to pain clinic for consideration of specialist analge-
sia review and/or injections, or to spinal orthopaedics for
consideration of surgery and/or injections, or to chronic pain
management services. Choice of pathway was based on cli-
nician’s judgment and patients’ preferences.
Data analysis
The following analyses were conducted for the whole
cohort, and separately for the subgroup clinically diagnosed
with sciatica.
Overall prognosis
Descriptive analysis was performed to describe the course
of patients’ disability and pain using mean (standard devia-
tion [SD]) scores for RMDQ and pain intensity (LBP and leg
pain) at baseline and each month, with 4 and 12 months being
the main follow-up points. The percentage of patients defined
as improved on the RMDQ was calculated.
Analysis of prognostic factors
A mixed-effects logistic regression model, which allows
all available outcome data at all three time points to be used,
accounts for autocorrelation due to repeated measures, and
gives valid inferences when data are assumed missing at
random, was used to estimate odds ratios (OR) and 95% con-
fidence interval (CI) for the association between each of the
potential prognostic factors and the binary outcome of im-
provement in disability. The model included an interaction
term between each predictor and time to obtain estimates (and
95% CI) for each point of follow-up (4 and 12 months).
Univariable associations were described, followed by a
series of models evaluating the prognostic value of the six
sets of variables relating to the six domains described in
Table 1.
Previous research and expertise has highlighted these six
domains as important, although it is unclear which factors
specifically are most strongly associated with outcome within
and between domains. Univariable analysis was first used to
examine associations between each factor and outcome. Each
model was then adjusted for (1) variables in the model only
(for models with more than 1 factor); (2) age, gender, body
mass index, smoking, and comorbidities; and (3) care path-
ways. Correlations between individual prognostic factors were
investigated using bivariate associations and variance infla-
tion factor, and if this was the case (variance inflation factor≥5),
then only one of the variables (with higher OR) was in-
cluded in analyses.
Finally, a combined model comprising all variables in the
six models was fitted to identify the strongest factors from
the six domains predicting long-term outcome. This was per-
formed with a backwards approach by removing nonsignificant
variables from the model one by one, until remaining vari-
ables had p<.05 (using the likelihood ratio test).
As a sensitivity analysis for addressing missing data, mul-
tiple imputation was employed by combining results from 40
multiply imputed datasets. Additional sensitivity analysis using
linear mixed model was also performed using numerical
RMDQ, with adjustment for baseline RMDQ score as the
outcome, as opposed to the binary classification. In a further
sensitivity analysis, a combined model using the subsample
of participants with sciatica and confirmed nerve root com-
pression on MRI was fitted.
In this study, the total number of factors considered com-
plied with the rule of at least 10 events per variable in the
logistic regression analysis [27].
Assessment of nonresponse
For primary follow-up time points (4 and 12 months), we
compared the key patient baseline characteristics (age, gender,
area deprivation, pain intensity, leg pain duration, and RMDQ
scores) for those followed up and those lost to follow-up.
Data were analyzed using Stata 13 (StataCorp. 2013,
College Station, TX, USA).
Results
Study sample
Six hundred nine patients were included in the study. Re-
sponse rates were 402 (66.0%) at 4 months and 450 (73.9%)
at 12 months; 74.2% (n=452) were clinically diagnosed as
having sciatica. The Figure presents the study flowchart. Base-
line characteristics of the study population are presented in
Table 2. Forty-seven percent, 41.5%, and 11.5% of patients
followed care pathways (1), (2), and (3), respectively. Four-
teen patients reported that they underwent spinal surgery and
21 had spinal injections.
Participants who did not respond to the 12-month ques-
tionnaire were more often male, younger, and had higher
baseline disability score compared with responders (see
Table S1 for details).
Prognosis of low back-related leg pain and sciatica
Overall, 55.0% of the cohort reported improvement at 12
months, both in the sciatica and in the referred leg pain sub-
groups. At baseline, mean disability was 12.6 (SD 5.7); this
had decreased to means of 8.2 (6.7) and 7.8 (7.0) at 4 and
12 months, respectively. Baseline mean back pain intensity
was 5.6 (2.2); this decreased to 3.4 (2.6) and 3.3 (2.7) at 4
and 12 months, respectively. For leg pain, mean baseline pain
intensity was 5.2 (2.4), falling to 2.8 (2.9) and 2.4 (2.7) at 4
and 12 months, respectively.
Prognostic factors associated with long-term changes in
disability
Table 3 shows all univariable associations between base-
line variables and disability. Multivariable analysis with
sequential adjustment for other variables in the models,
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demographics, and care pathways identified factors signifi-
cantly associated with outcome in each predefined domain
or variable set (presented in Tables 4 and 5). Longer leg pain
duration (OR 0.30, 95% CI 0.13–0.66), higher pain intensi-
ty (OR 0.84, CI 0.71–0.99), higher identity score (OR 0.68,
CI 0.50–0.93), and patient’s belief that the problem will last
a long time (OR 0.29, CI 0.14–0.60) were negatively asso-
ciated with improvement, whereas having myotomal weakness
(OR 4.56, CI 1.69–12.33) was positively associated with im-
provement. With the exception of pain intensity, the same
prognostic factors were significant in the sciatica subgroup.
Adjustment for demographics and care pathways did not
have a large impact on associations for most variables for all
domains (Tables 4 and 5).
Independent prognostic factors associated with long-term
changes in disability
For the whole cohort, the combined multivariable model
incorporating all variables from the six sets or domains showed
that longer leg pain duration (OR 0.41, CI 0.19–0.90), higher
identity score (OR 0.70, CI 0.53–0.93), and patient’s belief
that the problem will last a long time (OR 0.27, CI 0.13–
0.57) were the strongest independent prognostic factors
negatively associated with improvement. These last two factors
were similarly negatively associated with improvement in the
sciatica subgroup (Table 6). The sensitivity analyses using
multiple imputation and continuous RMDQ scores as the
outcome produced very similar results (data not presented).
The results from the sensitivity analysis using the subsample
with sciatica and corroborative MRI findings showed that
“identity” remained independently associated with outcome
(see Table S2).
Discussion
To our knowledge, this is the first comprehensive study
to describe prognosis and prognostic factors in patients seeking
care in primary care for back-related leg pain, including sci-
atica, of any duration and severity. The prognosis of low back-
related leg pain is similar in those with and without a clinical
diagnosis of sciatica, with 55% meeting the study’s criteri-
on for improvement in disability. The improvements in
disability from baseline in our cohort were similar, but mostly
higher (mean change score; 4.8), compared with some LBP
cohorts (UK) with or without leg pain, receiving primary care
including physiotherapy interventions ((4.3) [28], (2.4) [29]).
The percentage of patients with sciatica reporting improve-
ment (55%) at 1 year is within the range of reports from
secondary care populations, irrespective of outcome defini-
tion (range 32%–65%) [13,14,30].
In this study, we set out to specifically investigate prog-
nostic factors thought to be associated with long-term outcome
in low back-related leg pain and in sciatica and also examine
their independent effect.
The factors associated with improvement in disability in
this cohort were shorter pain duration, lower leg pain inten-
sity, fewer other symptoms associated with the back and leg
pain (lower identity score), patient’s belief that the problem
will be short-lived, and initially having myotomal weakness.
450 (73.9%) responded to the 
questionnaire at 12 month follow up
Patient Records Imported (n = 2087)
and Invitations Sent (n = 2087)
Appointment made (n = 1367)
Appointments attended (n = 1310)
No Appointment Made (n = 720)
Patients made no contact (n = 641)
Clinic Refusals (n = 41)
Pre-clinic Ineligibles (n = 38)
Eligible and consenting (n = 614)
In study (5 exclusions due 
to serious pathology on MRI)
Not Interested   (n = 356)
Not consenting  (n = 47)
Ineligible  (n = 293)
402 (66%) responded to the 
questionnaire at 4 month follow up
Fig. 1. Flowchart of study population.
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Table 2
Baseline characteristics of participants for the whole group and for the sciatica and referred leg pain subgroups
All participants
n=609
Sciatica subgroup
n=452
Referred leg pain
n=157
Sociodemographics (Denominator*)
Age (y) (609), mean (SD) 50.2 (13.9) 50.4 (14.0) 49.4 (13.7)
Gender (609), Female 381 (62.6) 276 (61.1) 105 (66.9)
BMI (609), mean (SD) 29.9 (7.0) 29.9 (6.3) 30.0 (8.7)
Current smoker (609) 194 (31.9) 151 (33.4) 43 (27.4)
Comorbidities† (609)
None 371 (60.9) 277 (61.3) 94 (59.9)
One other health problem 158 (25.9) 122 (27.0) 36 (22.9)
Two or more other health problems 80 (13.1) 53 (11.7) 27 (17.2)
Pain and function
RMDQ disability score (0–23) (609), mean (SD) 12.7 (5.7) 12.9 (5.7) 12.0 (5.7)
Back pain intensity (mean of 3 NRS) (609), mean (SD) 5.6 (2.2) 5.6 (2.2) 5.4 (2.1)
Leg pain intensity (mean of 3 NRS) (608), mean (SD) 5.2 (2.4) 5.6 (2.3) 4.1 (2.3)
Duration of symptoms
Back pain (607)
<6 wk 218 (35.9) 174 (38.6) 44 (28.2)
6–12 wk 126 (20.8) 96 (21.3) 30 (19.2)
3–6 mo 92 (15.2) 75 (16.6) 17 (10.9)
Over 6 mo 171 (28.2) 106 (23.5) 65 (41.7)
Leg pain (583)
<6 wk 251 (43.1) 192 (44.2) 59 (39.6)
6–12 wk 120 (20.6) 94 (21.7) 26 (17.5)
3–6 mo 84(14.4) 62 (14.3) 22 (14.8)
Over 6 mo 128 (22.0) 86 (19.8) 42 (28.0)
Leg pain is worse (609) 280 (46.0) 252 (55.8) 28 (17.8)
S-LANSS (possible neuropathic pain) (607) 332 (54.8) 232(51.6) 61 (39.0)
Psychological measures and perceptions
HADs depression subscale (continuous score) (609), mean (SD) 6.4 (4.0) 6.3 (4.0) 6.4 (4.0)
HADs depression subscale: categorized (609)
Normal (0–7) 392 (64.4) 295 (65.3) 97 (61.8)
Possible case (8–10) 119 (19.5) 82 (18.1) 37 (23.4)
Probable case (≥11) 98 (16.1) 75 (16.6) 23 (14.7)
Pain self-efficacy score‡ (593), mean (SD) 34.1 (14.6) 33.3 (14.7) 36.6 (13.9)
Illness perception
–Identity score§ (609), mean (SD) 5.9 (1.3) 5.9 (1.3) 5.9 (1.2)
–Timeline (“back/leg pain will last forever” [agree/strongly agree]) (609) 345 (56.7) 249 (55.1) 96 (61.2)
–Personal control (“what I do can determine whether back/leg pain gets
better/worse” [agree/strongly agree]) (605)
367 (60.7) 277 (61.8) 90 (57.3)
Clinical assessment
Pins and needles and/or numbness (patient reports having these symptoms) (609) 382 (62.7) 316 (69.9) 66 (42.0)
Cough, sneeze or strain (patient reports increased leg pain with cough/sneeze/strain) (609) 129 (21.2) 120 (26.6) 9 (5.7)
Leg pain is worse than back pain (patient report) (609) 280 (46.0) 252 (55.8) 28 (17.8)
Myotomal change (as per Oxford scale) (608)
5/5 (None) 503 (82.7) 347 (76.8) 156 (100)
4/5 92 (15.1) 92 (20.4) 0 (0.0)
0/5 or 1/5 or 2/5 or 3/5 13 (2.1) 13 (2.9) 0 (0.0)
Reflex change (at ankle or patella) (609)
None 490 (80.5) 341 (75.4) 149 (94.9)
Slightly reduced 30 (4.9) 30 (6.6) 0 (0.0)
Significantly reduced 22 (3.6) 19 (4.2) 3 (1.9)
Absent 67 (11.0) 62 (13.7) 5 (3.2)
Sensory change (as examined using a pin) (609)
None 356 (58.5) 226 (50.0) 130 (82.8)
Reduced pin/prick 201 (33.0) 175 (38.7) 26 (16.6)
Loss to pin/prick 52 (8.5) 51 (11.3) 1 (0.6)
Neural tension test positive (any) (609) 335 (55.0) 324 (71.7) 11 (7.0)
MRI (554)
Findings of nerve root compression 297 (53.6) 252 (60.7) 45 (32.4)
BMI, body mass index; HADs, Hospital Anxiety and Depression scale; NRS, Numerical Rating Scale; RMDQ, Roland-Morris Disability Questionnaire;
SD, standard deviation; S-LANSS, self-report Leeds Assessment Neuropathic Symptoms and Signs.
Note: All figures are frequencies and percentages (%), unless stated otherwise as mean and SD.
* The number of participants for each variable is shown in parentheses—the denominator varies for some participants due to missing data or not appli-
cable case.
† The health problems included chest problems, heart problems, raised blood pressure, diabetes, and circulation problems in the leg.
‡ Ten-item scale, score range=0–60—higher scores reflect stronger self-efficacy beliefs.
§ Sum of scores on seven symptoms—higher scores represent strongly held beliefs about number of symptoms attributed to the illness.
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Symptom duration and pain levels are similarly reported to
be associated with better outcomes in nonspecific LBP [31,32].
For the sciatica subgroup, pain intensity was not statisti-
cally significant after adjustment for care pathways, which
perhaps indicates that treatment modifies its effect (al-
though the strength of association fell by only 0.03). This
contrasts with the current secondary care literature which points
to leg pain severity in sciatica as likely associated with sub-
sequent surgery (proxy of poor outcome with conservative
management) [11]. More recently, Suri et al. [16] also did
not confirm leg pain intensity as being associated with dis-
ability in conservatively treated sciatica patients.
Depression was not found to be a significant factor when
included with other psychological variables in the model. This
is consistent with results from other studies, where factors
of “timeline” and “identity” are independent and stronger prog-
nostic factors in nonspecific LBP when compared to depression
[33]. In our cohort, the expectation of getting better soon was
only relevant in the long term, which may be indicative of
the interplay between natural course and initial treatment effect.
“Identity” was a significant prognostic factor for the sciati-
ca subgroup, across both time points, with decreased odds
of improvement for each increase in score. The “identity” score
was the sum of symptoms including sleep disturbance, fatigue,
unable to sit comfortably, all of which are often reported by
patients with back and leg pain, and sciatica, and may be rea-
sonably considered as an overall indication of severity or
impact of symptoms. However, both these characteristics may
well be influenced by patients’ behavior and psychological
profile, such as a pessimistic outlook for example.
We found that having myotomal weakness at baseline was
associated with improvement in disability at 12 months. All
patients with myotomal weakness had additional neuro-
logic signs (ie, reflex or sensory change). One recent study
in secondary care [14] also reported that myotomal weak-
ness was associated with improvement in one of their chosen
outcome measures (leg pain), but other studies report on
neurologic deficits and their likely association with
nonimprovement [13,34]. The finding of initial myotomal
weakness being associated with improvement may reflect the
fact that the most common reason for nerve root compres-
sion causing sciatic pain and neurological deficits, is a disc
prolapse, which often improves spontaneously leading to im-
provement in pain and disability. Another possibility is that
Table 3
Univariable associations between baseline variables and improvement in the RMDQ at 4 and 12 months for the whole group and sciatica subgroup based on
mixed-effects logistic regression model (statistically significant values in bold)
Improved vs. not improved: reference category in parentheses
All participants Sciatica subgroup
4 mo (n=402) 12 mo (n=450) 4 mo (n=308) 12 mo (n=338)
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Pain variables (Sets 1, 2, 3)
Duration of leg pain (<6 wk)
6–12 wk 0.73 (0.28–1.93) 1.02 (0.39–2.61) 0.55 (0.17–1.79) 1.10 (0.35–3.46)
Over 3 mo 0.16 (0.07–0.38) 0.23 (0.10–0.52) 0.09 (0.03–0.29) 0.19 (0.07–0.56)
Pain intensity (cont) 0.66 (0.55–0.79) 0.74 (0.63–0.89) 0.62 (0.49–0.79) 0.73 (0.58–0.91)
S-LANSS: possible neuropathic pain (No) 0.31 (0.14–0.65) 0.46 (0.23–0.93) 0.26 (0.10–0.66) 0.37 (0.15–0.92)
Psychological measures and perceptions (Set 4)
Pain self-efficacy 1.05 (1.02–1.08) 1.04 (1.01–1.06) 1.04 (1.01–1.08) 1.04 (1.01–1.08)
Illness perception
–Identity* 0.54 (0.40–0.73) 0.52 (0.38–0.69) 0.48 (0.33–0.69) 0.48 (0.33–0.70)
–Timeline† 0.33 (0.16–0.69) 0.20 (0.09–0.41) 0.29 (0.11–0.73) 0.12 (0.05–0.33)
–Personal control† 1.40 (0.66–2.96) 1.55 (0.76–3.18) 1.37 (0.54–3.51) 1.61 (0.65–4.00)
HADs depression (cont) 0.82 (0.75–0.91) 0.86 (0.78–0.94) 0.82 (0.73–0.93) 0.82 (0.73–0.93)
Clinical assessment and imaging (Set 5, 6)
Reporting pins and needles and/or numbness (No) 0.47 (0.22–1.02) 0.86 (0.42–1.76) 0.76 (0.30–1.93) 1.45 (0.59–3.58)
Increased leg pain with cough/sneeze/strain (No) 0.74 (0.29–1.87) 0.82 (0.34–1.94) 0.94 (0.32–2.79) 0.89 (0.32–2.47)
What is worse (Back pain) 1.58 (0·76–3.27) 1.13 (0.56–2.27) 3.15 (1.22–8.10) 1.95 (0.79–4.78)
Myotomes (No weakness [normal]) 1.66 (0.64–4.29) 2.62 (1.02–6.69) 2.08 (0.70–6.16) 3.22 (1.10–9.46)
Reflex (Normal)
Slightly reduced 0.19 (0.03–1.17) 0.72 (0.13–3.91) 0.18 (0.02–1.32) 0.69 (0.12–4.59)
Absent or significantly reduced 0.58 (0.20–1.68) 0.46 (0.17–1.30) 0.67 (0.19–2.32) 0.43 (0.13–1.44)
Sensation (Normal) 0.54 (0.25–1.13) 0.57 (0.28–1.17) 0.61 (0.24–1.53) 0.46 (0.19–1.12)
Neural tension test (Normal) 1.04 (0.50–2.16) 0.92 (0.46–1.85) 1.58 (0.59–4.23) 1.02 (0.39–2.68)
MRI finding: Nerve root compression (No) 1.07 (0.50–2.29) 1.06 (0.51–2.18) 1.00 (0.37–2.68) 1.08 (0.41–2.82)
CI, confidence interval; HADs, Hospital Anxiety and Depression scale; MRI, magnetic resonance imaging; OR, odds ratio; RMDQ, Roland-Morris Dis-
ability Questionnaire; S-LANSS, self-report Leeds Assessment Neuropathic Symptoms and Signs.
* Symptoms that the patient sees as part of the illness (0–7).
† Timeline and personal control are measured on a Likert scale: Strongly disagree—Disagree—Neither agree or disagree—Agree—Strongly agree. For
the purposes of the analysis, it was dichotomized (agree [agree, strongly agree] vs. disagree [strongly disagree, disagree, neither agree, or disagree]). The
reference for the analysis is “Strongly disagree/disagree/neither.”
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prognostic factors may be different in primary care cohorts,
such as ours, compared to secondary care cohorts [13].
Strengths and limitations
As the majority of patients with back-related leg pain and
sciatica are managed in primary care, one major strength of
our study is the primary care setting, thereby providing im-
portant new evidence in a sample that is more representative
of people with sciatica consulting healthcare than previ-
ously reported secondary care cohorts. The inclusion of
consecutive eligible patients with any degree of pain sever-
ity and duration of symptoms further strengthens the
generalizability of our findings, as these are applicable across
the spectrum of patient presentations and not only for those
populations with the most severe symptoms. The choice of
potential prognostic factors was comprehensive and under-
pinned by previous research and clinical experience. The
sensitivity analysis using the RMDQ continuous scales pro-
duced similar results to the primary analysis using the
dichotomous outcome increasing confidence in the results.
A potential limitation is the higher than expected attri-
tion; however, the multiple imputation sensitivity analysis
showed similar estimates. Another limitation is that, because
of small numbers in the referred leg pain subgroup, we were
unable to do separate analyses as we did in the sciatica sub-
group. We therefore cannot confirm that similar factors are
associated with outcome in patients with referred leg pain.
Table 4
Association of six preselected set of variables (models 1 to 6) with improvement in RMDQ at 4 and 12 months based on mixed-effects logistic regression
model for the whole group
Variables in the model
(Reference category)
4 mo (n=402) 12 mo (n=450)
Adjusted for all
the variables in
the model
Adjusted for the
variables in the
model and
demographics*
Adjusted for all
the variables in
the model,
demographics,
and care pathways
Adjusted for only
variables in the
model
Adjusted for the
variables in the
model and
demographics*
Adjusted for all
the variables in
the model,
demographics,
and care pathways
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Model 1
Duration of leg pain (<6 wk)
6–12 wk 0.73 (0.28–1.93) 0.67 (0.26–1.73) 0.81 (0.31–2.12) 1.02 (0.39–2.61) 0.87 (0.35–2.19) 0.92 (0.3–2.31)
Over 3 mo 0.16 (0.07–0.38) 0.22 (0.09–0.51) 0.26 (0.11–0.61) 0.23 (0.10–0.52) 0.29 (0.13–0.63) 0.30 (0.13–0.66)
Model 2
Pain intensity (cont) 0.66 (0.55–0.79) 0.71 (0.60–0.86) 0.76 (0.63–0.91) 0.75 (0.63–0.89) 0.82 (0.69–0.97) 0.84 (0.71–0.99)
Model 3
S-LANSS: possible
neuropathic origin (No)
0.31 (0.14–0.65) 0.37 (0.18–0.77) 0.44 (0.21–0.91) 0.46 (0.23–0.93) 0.60 (0.30–1.19) 0.65 (0.33–1.29)
Model 4
Pain self-efficacy 1.03 (0.99–1.06) 1.02 (0.99–1.06) 1.02 (0.99–1.05) 1.00 (0.97–1.03) 0.99 (0.96–1.02) 0.99 (0.96–1.03)
Illness perception
–Identity 0.64 (0.46–0.88) 0.74 (0.54–1.00) 0.77 (0.56–1.05) 0.58 (0.42–0.80) 0.67 (0.49–0.91) 0.68 (0.50–0.93)
–Timeline 0.52 (0.25–1.11) 0.49 (0.23–1.01) 0.55 (0.26–1.16) 0.31 (0.15–0.65) 0.28 (0.13–0.59) 0.29 (0.14–0.60)
–Personal control 1.49 (0.69–3.19) 1.57 (0.75–3.27) 1.48 (0.70–3.13) 1.52 (0.73–3.17) 1.61 (0.79–3.30) 1.60 (0.78–3.29)
HAD depression (cont) 0.95 (0.84–1.08) 0.96 (0.84–1.08) 0.96 (0.84–1.09) 0.96 (0.85–1.08) 0.96 (0.85–1.08) 0.96 (0.85–1.09)
Model 5
Reporting pins and needles
and/or numbness (No)
0.57 (0.26–1.26) 0.61 (0.28–1.33) 0.66 (0.30–1.44) 1.02 (0.48–2.17) 1.23 (0.59–2.57) 1.32 (0.63–2.76)
Increased leg pain with
cough/sneeze/strain (No)
0.78 (0.29–2.11) 0.62 (0.24–1.64) 0.82 (0.30–2.19) 0.83 (0.33–2.09) 0.71 (0.29–1.74) 0.77 (0.31–1.88)
What is worse (Back pain) 1.65 (0.74–3.68) 1.74 (0.80–3.78) 1.72 (0.79–3.74) 1.18 (0.55–2.53) 1.24 (0.60–2.59) 1.28 (0.61–2.66)
Myotomes (No weakness
[normal])
2.61 (0.92–7.41) 2.69 (0.98–7.40) 3.47 (1.22–9.82) 3.92 (1.42–10.83) 4.10 (1.53–11.00) 4.56 (1.69–12.33)
Reflex (Normal)
Slightly reduced 0.14 (0.02–0.91) 0.16 (0.03–1.00) 0.16 (0.03–1.01) 0.52 (0.09–2.95) 0.57 (0.10–3.07) 0.58 (0.11–3.11)
Absent or significantly
reduced
0.53 (0.18–1.58) 0.47 (0.16–1.35) 0.53 (0.18–1.54) 0.41 (0.15–1.17) 0.35 (0.13–0.98) 0.38 (0.14–1.05)
Sensation (Normal) 0.53 (0.24–1.16) 0.66 (0.31–1.42) 0.74 (0.34–1.59) 0.49 (0.23–1.05) 0.65 (0.31–1.36) 0.67 (0.33–1.40)
Neural tension test (Normal) 1.04 (0.46–2.36) 0.95 (0.43–2.09) 1.01 (0.45–2.25) 0.88 (0.40–1.96) 0.75 (0.35–1.63) 0.80 (0.37–1.73)
Model 6
MRI finding: Nerve root
compression (No)
1.07 (0.50–2.29) 0.95 (0.45–2.00) 1.30 (0.60–2.80) 1.06 (0.51–2.18) 0.95 (0.47–1.93) 1.05 (0.51–2.15)
CI, confidence interval; HADs, Hospital Anxiety and Depression scale; MRI, magnetic resonance imaging; OR, odds ratio; RMDQ, Roland-Morris Dis-
ability Questionnaire; S-LANSS, self-report Leeds Assessment Neuropathic Symptoms and Signs.
* Adjusted for age, gender, body mass index, smoking, and comorbidities.
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Another issue is the potential confounding by treatment,
where beneficial effects of treatment may influence the as-
sociation between prognostic factors and outcome [35,36].
To address this issue, we estimated the strength of associa-
tion with and without adjustment for care pathways. As results
remained broadly similar, we are reassured that treatment did
not have a significant impact on our findings. A further lim-
itation in terms of treatment may be the use of analgesic
medication. Patients were treated as per usual practice as
regards analgesia; however, we do not have data on this and
therefore we are not able to adjust for or comment on the po-
tential effect of analgesic use.
Lastly, it is important to consider the issue of uncertain-
ty when diagnosing sciatica versus referred leg pain, and the
potential for misclassification. In the absence of a “gold stan-
dard” for the diagnosis of sciatica, diagnosis in this study was
based on clinical opinion based on the clinical assessment
findings, which reflects normal primary care practice. Ex-
tensive discussion of these points is presented elsewhere [18].
However, the baseline (clinical examination) characteristics
of the subgroup clinically diagnosed with sciatica are clearly
different from those of the subgroup diagnosed with re-
ferred leg pain, and in line with the symptoms and signs
expected to be present in the clinical diagnosis of sciatica,
although the possibility of misclassification still remains. Fur-
thermore, the sensitivity analysis using the subsample with
clinical diagnosis of sciatica and corroborative MRI find-
ings of nerve root compression found the same factor (identity)
Table 5
Association of six preselected set of variables (models 1 to 6) with improvement in RMDQ at 4 and 12 months based on mixed-effects logistic regression
model for the sciatica subgroup
Variables in the model
(Reference category)
4 mo (n=308) 12 mo (338)
Adjusted for all
the variables in
the model
Adjusted for the
variables in the
model and
demographics*
Adjusted for all
the variables in
the model,
demographics,
and care pathways
Adjusted for only
variables in the
model
Adjusted for the
variables in the
model and
demographics*
Adjusted for all
the variables in
the model,
demographics,
and care pathways
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Model 1
Duration of leg pain (<6 wk)
6–12 wk 0.55 (0.17–1.79) 0.50 (0.16–1.60) 0.65 (0.19–2.19) 1.10 (0.35–3.46) 0.96 (0.31–2.92) 1.01 (0.31–3.22)
Over 3 mo 0.09 (0.03–0.28) 0.14 (0.05–0.41) 0.16 (0.05–0.50) 0.19 (0.07–0.56) 0.26 (0.09–0.73) 0.23 (0.08–0.69)
Model 2
Pain intensity (cont) 0.62 (0.49–0.79) 0.69 (0.54–0.87) 0.75 (0.59–0.95) 0.73 (0.58–0.91) 0.78 (0.63–0.98) 0.81 (0.64–1.01)
Model 3
S-LANSS: possible
neuropathic pain (No)
0.26 (0.10–0.66) 0.32 (0.13–0.81) 0.37 (0.14–0.96) 0.37 (0.15–0.92) 0.50 (0.21–1.19) 0.52 (0.21–1.26)
Model 4
Pain self-efficacy 1.01 (0.97–1.04) 1.01 (0.97–1.05) 1.00 (0.9–1.04) 0.99 (0.96–1.04) 0.99 (0.96–1.04) 0.99 (0.95–1.03)
Illness perception
–Identity 0.54 (0.36–0.80) 0.63 (0.43–0.91) 0.65 (0.44–0.96) 0.56 (0.38–0.83) 0.64 (0.44–0.94) 0.64 (0.43–0.95)
–Timeline 0.48 (0.19–1.22) 0.49 (0.20–1.21) 0.58 (0.22–1.51) 0.20 (0.08–0.53) 0.22 (0.08–0.55) 0.21 (0.08–0.54)
–Personal control 1.53 (0.59–3.92) 1.62 (0.65–4.02) 1.46 (0.56–3.82) 1.43 (0.57–3.62) 1.50 (0.62–3.63) 1.51 (0.60–3.81)
HADs depression (cont) 0.94 (0.80–1.10) 0.94 (0.80–1.10) 0.94 (0.80–1.11) 0.93 (0.80–1.08) 0.93 (0.81–1.08) 0.93 (0.78–1.09)
Model 5
Reporting pins and needles
and/or numbness (No)
0.47 (0.16–1.34) 0.57 (0.20–1.60) 0.62 (0.21–1.84) 0.93 (0.43–2.54) 1.20 (0.45–3.19) 1.37 (0.50–3.74)
Increased leg pain with
cough/sneeze/strain (No)
0.87 (0.28–2.77) 0.56 (0.18–1.74) 0.74 (0.23–2.45) 0.83 (0.29–2.43) 0.66 (0.23–1.91) 0.68 (0.23–2.00)
What is worse (Back pain) 3.00 (1.09–8.25) 3.07 (1.15–8.21) 3.10 (1.12–8.62) 2.01 (0.77–5.26) 1.98 (0.78–5.00) 2.12 (0.85–5.73)
Myotomes (No weakness
[normal])
2.75 (0.86–8.77) 2.92 (0.94–9.09) 4.31 (1.27–14.63) 4.57 (1.45–14.40) 4.57 (1.51–13.82) 5.62 (1.76–17.92)
Reflex (Normal)
Slightly reduced 0.11 (0.01–0.92) 0.12 (0.01–0.99) 0.12 (0.01–1.07) 0.46 (0.07–3.19) 0.51 (0.08–3.34) 0.56 (0.08–3.79)
Absent or significantly
reduced
0.56(0.16–2.01) 0.45 (0.13–1.58) 0.48 (0.13–1.83) 0.35 (0.10–1.21) 0.30 (0.09–1.02) 0.35 (0.10–1.20)
Sensation (Normal) 0.63 (0.24–1.65) 0.82 (0.32–2.07) 1.03 (0.39–2.72) 0.40 (0.16–1.03) 0.53 (0.22–1.30) 0.56 (0.23–1.41)
Neural tension test (Normal
(negative)
1.22 (0.43–3.46) 1.13 (0.41–3.12) 1.28 (0.44–3.74) 0.84 (0.30–2.35) 0.68 (0.25–1.87) 0.81 (0.29–2.27)
Model 6
MRI finding: Nerve root
compression (No)
1.00 (0.37–2.68) 0.71 (0.27–1.88) 1.08 (0.38–3.05) 1.08 (0.42–2.82) 0.82 (0.32–2.09) 0.89 (0.33–2.39)
CI, confidence interval; HADs, Hospital Anxiety and Depression scale; MRI, magnetic resonance imaging; OR, odds ratio; RMDQ, Roland-Morris Dis-
ability Questionnaire; S-LANSS, self-report Leeds Assessment Neuropathic Symptoms and Signs.
* Adjusted for age, gender, body mass index, smoking, and comorbidities.
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associated with outcome, which indicates that the influence
of potential diagnostic misclassification on results does not
appear to be significant.
Suggestions for further research
Of the prognostic factors we investigated, independent pre-
dictors of improvement were similar in the whole sample and
in the sciatica subgroup (which was the largest), with clini-
cal characteristics more weakly associated with outcome and
no longer significant in the combined model. This suggests
that long-term outcome may be more strongly influenced by
factors indicative of overall impact of the condition as indi-
cated by the “identity” variable; therefore, this should influence
early management and treatment intensity. Although we in-
cluded most factors currently considered potentially important,
it is possible that there are still unknown characteristics es-
pecially relevant to sciatica that we are not capturing, and
which may better guide choice of intensity and timing of dif-
ferent care pathways. More specific MRI findings (eg, size
of disc herniation) were not included as prognostic vari-
ables, mainly because of the primary care setting, which does
not include routine MRI for this population. However, MRI
characteristics can be investigated in further analysis to assess
their contribution to the generic factors identified in this study.
We could not disentangle whether the prognostic factors
mediate or moderate treatment effect. Further research in-
vestigating different models of care (eg, early and intensive
interventions for patients with high overall impact of symptoms
and a reduced expectation of a timely recovery versus current
models of “stepped” care), and incorporating the prognostic
factors this study identified, may elucidate which factors are
prognostic and which are predictive of treatment outcome.
Conclusions
At 1 year, 55.0% of primary care patients with low
back-related leg pain and sciatica receiving current best
care reported a 30% or more improvement in disability. In
the long term, patients’ belief that they will get better soon,
and not having many other complaints attributed to the
back and leg pain, were independent prognostic factors as-
sociated with improvement. These prognostic factors can
be used to inform and direct management decisions about
timing and intensity of available therapeutic options for
symptoms relief, especially in sciatica patients with corrob-
orative MRI findings, for whom there are potentially
appropriate therapeutic interventions that are not applicable
for patients with nonspecific low back and leg symptoms.
Exploration and appropriate handling of patient’s expecta-
tions about their pain trajectory, both in referred leg pain
and in sciatica cases, is considered relevant, similarly to
most health problems presentations.
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Table 6
Multivariable associations between baseline characteristics and improvement in the RMDQ for the whole group and the sciatica group, combining all the six
preselected set of variables
Variables in the
final model
(Reference category)
4 mo 12 mo
Adjusted for all
the variables in
the final model
Adjusted for the
variables in the
model and
demographics*
Adjusted for all
the variables in
the model,
demographics,
and care pathways
Adjusted for all
the variables in
the final model
Adjusted for the
variables in the
model and
demographics*
Adjusted for all
the variables in
the model,
demographics,
and care pathways
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Whole group
Duration of leg pain (>6 wk)
6–12 wk 0.79 (0.30–2.10) 0.75 (0.29–1.94) 0.85 (0.32–2.24) 1.11 (0.43–2.84) 1.03 (0.41–2.56) 1.04 (0.41–2.62)
Over 3 mo 0.23 (0.10–0.55) 0.28 (0.12–0.64) 0.31 (0.13–0.72) 0.36 (0.16–0.79) 0.42 (0.19–0.92) 0.41 (0.19–0.90)
–Timeline — — — 0.31 (0.15–0.64) 0.27 (0.13–0.56) 0.27 (0.13–0.57)
Pain intensity (cont) 0.75 (0.63–0.91) 0.80 (0.67–0.96) 0.81 (0.67–0.97) — — —
–Identity 0.66 (0.49–0.89) 0.73 (0.54–0.97) 0.74 (0.54–0.99) 0.59 (0.44–0.79) 0.69 (0.52–0.91) 0.70 (0.53–0.93)
Sciatica subgroup
Duration of leg pain (>6 wk)
6–12 wk 0.58 (0.18–1.86) 0.56 (0.18–1.76) 0.66 (0.20–2.20) 1.30 (0.41–4.10) 1.27 (0.41–3.82) 1.29 (0.40–4.19)
Over 3 mo 0.15 (0.05–0.46) 0.19 (0.07–0.57) 0.20 (0.06–0.63) 0.31 (0.11–0.88) 0.41 (0.15–1.11) 0.34 (0.11–1.01)
–Timeline — — — 0.21 (0.08–0.55) 0.22 (0.09–0.56) 0.21 (0.08–0.56)
Pain intensity (cont) 0.70 (0.54–0.89) 0.75 (0.59–0.96) 0.79 (0.62–1.02) — — —
–Identity 0.63 (0.43–0.90) 0.69 (0.49–0.99) 0.74 (0.51–1.07) 0.57 (0.39–0.81) 0.64 (0.45–0.91) 0.65 (0.45–0.94)
What is worse (back pain) 3.47 (1.32–9.11) 3.15 (1.22–8.12) 3.37 (1.25–9.08) — — —
CI, confidence interval; OR, odds ratio; RMDQ, Roland-Morris Disability Questionnaire.
Note: Only the variables that were statistically significant in the final combined model are presented.
* Adjusted for age, gender, body mass index, smoking, and comorbidities.
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